Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | XIAP | P98170 | 1/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CTRB1 | P17538 | 4/20 | 0.49 |
| ▸ | ALPL | P05186 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.47 |
| ▸ | CPA1 | P15085 | 2/20 | 0.47 |
| ▸ | CPA3 | P15088 | 2/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8277429 | 1.00 | ALPI (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL8915021 | 1.00 | ALPI (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL17539605 | 0.85 | FFAR1 (0.57) | — | |
| Acetone SCHEMBL16013120 | 0.85 | ALPI (0.59) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL9513107 | 0.84 | TRPA1 (0.52) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL14501335 | 0.83 | MAOB (0.60) | PTGS1 | |
| SCHEMBL7773534 | 0.83 | ALPI (0.52) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL8953468 | 0.82 | CYP1A2 (0.64) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL197252 | 0.82 | CYP1A2 (0.64) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL57558 | 0.82 | CYP1A2 (0.64) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4247791-A2 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2023-09-27 | — | — | EP | claimed |
| WO-2023143741-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2023-08-03 | — | — | WO | claimed |
| WO-2023144326-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2023-08-03 | — | — | WO | claimed |
| WO-2022106452-A2 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2022-05-27 | — | — | WO | claimed |
| WO-2022105986-A1 | NOVEL COOLING AGENTS AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2022-05-27 | — | — | WO | claimed |
| EP-3413906-B1 | CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES | UNIV LOUISIANA STATE (US) | 2021-10-27 | — | — | EP | claimed |
| CN-109475595-A | Composition, method and purposes are combined in treatment of cancer | 路易斯安那州立大学以及农业和机械学院监事会 | 2019-03-15 | — | — | CN | claimed |
| EP-3413906-A1 | CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES | The Board of Supervisors of Louisiana State University & Agricultural & Mechanical College (US) | 2018-12-19 | — | — | EP | claimed |
| US-20170258929-A1 | CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2017-09-14 | — | — | US | claimed |
| WO-2017139644-A1 | CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2017-08-17 | — | — | WO | claimed |
| EP-2385098-A1 | Method for manufacturing an aroma concentrate and aroma concentrate | Symrise AG (DE) | 2011-11-09 | — | — | EP | claimed |
| EP-2075321-B1 | Method for manufacturing an aroma concentrate and aroma concentrate | SYMRISE AG (DE) | 2011-08-03 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| EP-2075321-A1 | Method for manufacturing an aroma concentrate and aroma concentrate | Symrise GmbH & Co. KG (DE) | 2009-07-01 | — | — | EP | claimed |
| EP-2075320-A1 | Method for manufacturing an aroma concentrate and aroma concentrate | Symrise GmbH & Co. KG (DE) | 2009-07-01 | — | — | EP | claimed |
| US-20090155446-A1 | PROCESS FOR THE PREPARATION OF A FLAVORING CONCENTRATE, AND A FLAVORING CONCENTRATE | SYMRISE GMBH & CO. KG (DE) | 2009-06-18 | — | — | US | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170258929-A1 | CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES | GNRHR, LHCGR, MKI67 | ALPI 1967/4885PKM 2022/4885PTGS1 264/4885 |
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | ALPI 868/4885PKM 691/4885PTGS1 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.